1887

Chapter 75 : Combined Immunodeficiencies

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Combined Immunodeficiencies, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818722/9781555818715_CH75-1.gif /docserver/preview/fulltext/10.1128/9781555818722/9781555818715_CH75-2.gif

Abstract:

This chapter is dedicated to describing combined immunodeficiencies (CIDs) and useful diagnostic assays. Here, a CID is defined as a defect that affects the two most prominent arms of the adaptive immune system: T cells and B cells. The molecular defect may directly affect both cell types or just one cell type, specifically T lymphocytes, with indirect effects on B-cell function. CIDs are distinguished from severe combined immunodeficiencies (SCIDs) because T-cell numbers and function are higher than per established criteria for SCID and thus may not be detected on SCID newborn screening (NBS). Several CIDs are attributed to distinct genetic mutations in SCID-associated genes. In recent years, the field of immunology has witnessed increased reporting of unique CIDs affecting isolated families or small numbers of individuals. This increase is attributable to the advent of improved genetic testing, such as whole-exome sequencing. In Table 1, we provide a comprehensive list of CIDs, their immunophenotypes, and useful diagnostic tests. Common themes for CIDs include aberrant T-cell development, function, cytoskeletal regulation, and survival. These defects translate to clinical problems secondary to immune deficiency and, in many instances, immune dysregulation. This chapter does not include in-depth description of all CIDs but rather focuses on categorical descriptions and highlights more prevalent genetic abnormalities along with overviews of diagnostic assays for CID confirmation.

Citation: Seroogy C, Elder M. 2016. Combined Immunodeficiencies, p 721-736. In Detrick B, Schmitz J, Hamilton R (ed), Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818722.ch75
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555818722.ch75
1. Zimmer J, Andrès E, Donato L, Hanau D, Hentges F, de la Salle H. 2005. Clinical and immunological aspects of HLA class I deficiency. QJM 98:719727.[CrossRef].[PubMed]
2. Griscelli C. 1991. Combined immunodeficiency with defective expression in major histocompatibility complex class II genes. Clin Immunol Immunopathol 61:S106S110.[PubMed].[CrossRef]
3. Lev A, Simon AJ, Broides A, Levi J, Garty BZ, Rosenthal E, Amariglio N, Rechavi G, Somech R. 2013. Thymic function in MHC class II-deficient patients. J Allergy Clin Immunol 131:831839.[CrossRef].[PubMed]
4. de la Calle-Martin O, Hernandez M, Ordi J, Casamitjana N, Arostegui JI, Caragol I, Ferrando M, Labrador M, Rodriguez-Sanchez JL, Espanol T. 2001. Familial CD8 deficiency due to a mutation in the CD8α gene. J Clin Invest 108:117123.[CrossRef].[PubMed]
5. de la Fuente MA, Recher M, Rider NL, Strauss KA, Morton DH, Adair M, Bonilla FA, Ochs HD, Gelfand EW, Pessach IM, Walter JE, King A, Giliani S, Pai SY, Notarangelo LD. 2011. Reduced thymic output, cell cycle abnormalities, and increased apoptosis of T lymphocytes in patients with cartilage-hair hypoplasia. J Allergy Clin Immunol 128:139146.[CrossRef].[PubMed]
6. Nehme NT, Pachlopnik Schmid J, Debeurme F, André-Schmutz I, Lim A, Nitschke P, Rieux-Laucat F, Lutz P, Picard C, Mahlaoui N, Fischer A, de Saint Basile G. 2012. MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival. Blood 119:34583468.[CrossRef].[PubMed]
7. Shiow LR, Paris K, Akana MC, Cyster JG, Sorensen RU, Puck JM. 2009. Severe combined immunodeficiency (SCID) and attention deficit hyperactivity disorder (ADHD) associated with a Coronin-1A mutation and a chromosome 16p11.2 deletion. Clin Immunol 131:2430.[CrossRef].[PubMed]
8. Villa A, Santagata S, Bozzi F, Giliani S, Frattini A, Imberti L, Gatta LB, Ochs HD, Schwarz K, Notarangelo LD, Vezzoni P, Spanopoulou E. 1998. Partial V(D)J recombination activity leads to Omenn syndrome. Cell 93:885896.[PubMed].[CrossRef]
9. Giliani S, Bonfim C, de Saint Basile G, Lanzi G, Brousse N, Koliski A, Malvezzi M, Fischer A, Notarangelo LD, Le Deist F. 2006. Omenn syndrome in an infant with IL7RA gene mutation. J Pediatr 148:272274.[CrossRef].[PubMed]
10. Mancebo E, Recio MJ, Martínez-Busto E, González-Granado LI, Rojo P, Fernández-Díaz E, Ruiz-Contreras J, Paz-Artal E, Allende LM. 2011. Possible role of Artemis c.512C>G polymorphic variant in Omenn syndrome. DNA Repair (Amst) 10:34.[CrossRef].[PubMed]
11. Henderson LA, Frugoni F, Hopkins G, Al-Herz W, Weinacht K, Comeau AM, Bonilla FA, Notarangelo LD, Pai SY. 2013. First reported case of Omenn syndrome in a patient with reticular dysgenesis. J Allergy Clin Immunol 131:12271230.[CrossRef].[PubMed]
12. Shiloh Y, Ziv Y. 2013. The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat Rev Mol Cell Biol 14:197210.[CrossRef].[PubMed]
13. Arnaiz-Villena A, Timon M, Corell A, Perez-Aciego P, Martin-Villa JM, Regueiro JR. 1992. Brief report: primary immunodeficiency caused by mutations in the gene encoding the CD3-γ subunit of the T-lymphocyte receptor. N Engl J Med 327:529533.[CrossRef].[PubMed]
14. Dadi HK, Simon AJ, Roifman CM. 2003. Effect of CD3δ deficiency on maturation of α/β and γ/δ T-cell lineages in severe combined immunodeficiency. N Engl J Med 349:18211828.[CrossRef].[PubMed]
15. Soudais C, de Villartay JP, Le Deist F, Fischer A, Lisowska-Grospierre B. 1993. Independent mutations of the human CD3-ε gene resulting in a T cell receptor/CD3 complex immunodeficiency. Nat Genet 3:7781.[CrossRef].[PubMed]
16. Qamar N, Fuleihan RL. 2014. The hyper IgM syndromes. Clin Rev Allergy Immunol 46:120130.[CrossRef].[PubMed]
17. Gorska MM, Liang Q, Karim Z, Alam R. 2009. Uncoordinated 119 protein controls trafficking of Lck via the Rab11 endosome and is critical for immunological synapse formation. J Immunol 183:16751684.[CrossRef].[PubMed]
18. Goldman FD, Ballas ZK, Schutte BC, Kemp J, Hollenback C, Noraz N, Taylor N. 1998. Defective expression of p56lck in an infant with severe combined immunodeficiency. J Clin Invest 102:421429.[CrossRef].[PubMed]
19. Elder ME, Lin D, Clever J, Chan AC, Hope TJ, Weiss A, Parslow TG. 1994. Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase. Science 264:15961599.[PubMed].[CrossRef]
20. Gorska MM, Alam R. 2012. A mutation in the human Uncoordinated 119 gene impairs TCR signaling and is associated with CD4 lymphopenia. Blood 119:13991406.[CrossRef].[PubMed]
21. Poliani PL, Facchetti F, Ravanini M, Gennery AR, Villa A, Roifman CM, Notarangelo LD. 2009. Early defects in human T-cell development severely affect distribution and maturation of thymic stromal cells: possible implications for the pathophysiology of Omenn syndrome. Blood 114:105108.[CrossRef].[PubMed]
22. Sharfe N, Shahar M, Roifman CM. 1997. An interleukin-2 receptor γ chain mutation with normal thymus morphology. J Clin Invest 100:30363043.[CrossRef].[PubMed]
23. Frucht DM, Gadina M, Jagadeesh GJ, Aksentijevich I, Takada K, Bleesing JJ, Nelson J, Muul LM, Perham G, Morgan G, Gerritsen EJ, Schumacher RF, Mella P, Veys PA, Fleisher TA, Kaminski ER, Notarangelo LD, O'Shea JJ, Candotti F. 2001. Unexpected and variable phenotypes in a family with JAK3 deficiency. Genes Immun 2:422432.[CrossRef].[PubMed]
24. Sharfe N, Dadi HK, Shahar M, Roifman CM. 1997. Human immune disorder arising from mutation of the α chain of the interleukin-2 receptor. Proc Natl Acad Sci USA 94:31683171.[PubMed].[CrossRef]
25. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27:2021.[CrossRef].[PubMed]
26. Bernasconi A, Marino R, Ribas A, Rossi J, Ciaccio M, Oleastro M, Ornani A, Paz R, Rivarola MA, Zelazko M, Belgorosky A. 2006. Characterization of immunodeficiency in a patient with growth hormone insensitivity secondary to a novel STAT5b gene mutation. Pediatrics 118:e1584e1592.[CrossRef].[PubMed]
27. Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, Freeman AF, Demidowich A, Davis J, Turner ML, Anderson VL, Darnell DN, Welch PA, Kuhns DB, Frucht DM, Malech HL, Gallin JI, Kobayashi SD, Whitney AR, Voyich JM, Musser JM, Woellner C, Schäffer AA, Puck JM, Grimbacher B. 2007. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 357:16081619.[CrossRef].[PubMed]
28. Woellner C, Gertz EM, Schäffer AA, Lagos M, Perro M, Glocker EO, Pietrogrande MC, Cossu F, Franco JL, Matamoros N, Pietrucha B, Heropolitańska-Pliszka E, Yeganeh M, Moin M, Español T, Ehl S, Gennery AR, Abinun M, Breborowicz A, Niehues T, Kilic SS, Junker A, Turvey SE, Plebani A, Sánchez B, Garty BZ, Pignata C, Cancrini C, Litzman J, Sanal O, Baumann U, Bacchetta R, Hsu AP, Davis JN, Hammarström L, Davies EG, Eren E, Arkwright PD, Moilanen JS, Viemann D, Khan S, Maródi L, Cant AJ, Freeman AF, Puck JM, Holland SM, Grimbacher B. 2010. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol 125:424432.e8. doi:10.1016/j.jaci.2009.10.059.[CrossRef].[PubMed] http://dx.doi.org/doi:10.1016/j.jaci.2009.10.059
29. Grunebaum E, Cohen A, Roifman CM. 2013. Recent advances in understanding and managing adenosine deaminase and purine nucleoside phosphorylase deficiencies. Curr Opin Allergy Clin Immunol 13:630638.[CrossRef].[PubMed]
30. Jain A, Ma CA, Liu S, Brown M, Cohen J, Strober W. 2001. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol 2:223228.[CrossRef].[PubMed]
31. Zonana J, Elder ME, Schneider LC, Orlow SJ, Moss C, Golabi M, Shapira SK, Farndon PA, Wara DW, Emmal SA, Ferguson BM. 2000. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am J Hum Genet 67:15551562.[CrossRef].[PubMed]
32. Courtois G, Smahi A, Reichenbach J, Döffinger R, Cancrini C, Bonnet M, Puel A, Chable-Bessia C, Yamaoka S, Feinberg J, Dupuis-Girod S, Bodemer C, Livadiotti S, Novelli F, Rossi P, Fischer A, Israël A, Munnich A, Le Deist F, Casanova JL. 2003. A hypermorphic IκBα mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J Clin Invest 112:11081115.[CrossRef].[PubMed]
33. Ariga T, Nakajima M, Yoshida J, Yamato K, Nagatoshi Y, Yanai F, Caviles AP, Nelson DL, Sakiyama Y. 2004. Confirming or excluding the diagnosis of Wiskott-Aldrich syndrome in children with thrombocytopenia of an unknown etiology. J Pediatr Hematol Oncol 26:435440.[PubMed].[CrossRef]
34. Su HC. 2010. Dedicator of cytokinesis 8 (DOCK8) deficiency. Curr Opin Allergy Clin Immunol 10:515520.[CrossRef].[PubMed]
35. Dasouki M, Okonkwo KC, Ray A, Folmsbeel CK, Gozales D, Keles S, Puck JM, Chatila T. 2011. Deficient T Cell Receptor Excision Circles (TRECs) in autosomal recessive hyper IgE syndrome caused by DOCK8 mutation: implications for pathogenesis and potential detection by newborn screening. Clin Immunol 141:128132.[CrossRef].[PubMed]
36. Coffey AJ, Brooksbank RA, Brandau O, Oohashi T, Howell GR, Bye JM, Cahn AP, Durham J, Heath P, Wray P, Pavitt R, Wilkinson J, Leversha M, Huckle E, Shaw-Smith CJ, Dunham A, Rhodes S, Schuster V, Porta G, Yin L, Serafini P, Sylla B, Zollo M, Franco B, Bolino A, Seri M, Lanyi A, Davis JR, Webster D, Harris A, Lenoir G, de St Basile G, Jones A, Behloradsky BH, Achatz H, Murken J, Fassler R, Sumegi J, Romeo G, Vaudin M, Ross MT, Meindl A, Bentley DR. 1998. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet 20:129135.[CrossRef].[PubMed]
37. Sayos J, Wu C, Morra M, Wang N, Zhang X, Allen D, van Schaik S, Notarangelo L, Geha R, Roncarolo MG, Oettgen H, De Vries JE, Aversa G, Terhorst C. 1998. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 395:462469.[CrossRef].[PubMed]
38. Marsh RA, Madden L, Kitchen BJ, Mody R, McClimon B, Jordan MB, Bleesing JJ, Zhang K, Filipovich AH. 2010. XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. Blood 116:10791082.[CrossRef].[PubMed]
39. Rigaud S, Fondanèche MC, Lambert N, Pasquier B, Mateo V, Soulas P, Galicier L, Le Deist F, Rieux-Laucat F, Revy P, Fischer A, de Saint Basile G, Latour S. 2006. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 444:110114.[CrossRef].[PubMed]
40. Speckmann C, Lehmberg K, Albert MH, Damgaard RB, Fritsch M, Gyrd-Hansen M, Rensing-Ehl A, Vraetz T, Grimbacher B, Salzer U, Fuchs I, Ufheil H, Belohradsky BH, Hassan A, Cale CM, Elawad M, Strahm B, Schibli S, Lauten M, Kohl M, Meerpohl JJ, Rodeck B, Kolb R, Eberl W, Soerensen J, von Bernuth H, Lorenz M, Schwarz K, Zur Stadt U, Ehl S. 2013. X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis. Clin Immunol 149:133141.[CrossRef].[PubMed]
41. Marsh RA, Bleesing JJ, Filipovich AH. 2010. Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency. J Immunol Methods 362:19.[CrossRef].[PubMed]
42. Krutzik PO, Irish JM, Nolan GP, Perez OD. 2004. Analysis of protein phosphorylation and cellular signaling events by flow cytometry: techniques and clinical applications. Clin Immunol 110:206221.[CrossRef].[PubMed]
43. Wiszniewski W, Fondaneche MC, Le Deist F, Kanariou M, Selz F, Brousse N, Steimle V, Barbieri G, Alcaide-Loridan C, Charron D, Fischer A, Lisowska-Grospierre B. 2001. Mutation in the class II trans-activator leading to a mild immunodeficiency. J Immunol 167:17871794. (Erratum, 169:607, 2002.)[PubMed].[CrossRef]
44. Schuetz C, Huck K, Gudowius S, Megahed M, Feyen O, Hubner B, Schneider DT, Manfras B, Pannicke U, Willemze R, Knüchel R, Göbel U, Schulz A, Borkhardt A, Friedrich W, Schwarz K, Niehues T. 2008. An immunodeficiency disease with RAG mutations and granulomas. N Engl J Med 358:20302038.[CrossRef].[PubMed]
45. Avila EM, Uzel G, Hsu A, Milner JD, Turner ML, Pittaluga S, Freeman AF, Holland SM. 2010. Highly variable clinical phenotypes of hypomorphic RAG1 mutations. Pediatrics 126:e1248e1252. doi:10.1542/peds.2009-3171.[CrossRef].[PubMed] http://dx.doi.org/doi:10.1542/peds.2009-3171
46. Kuijpers TW, Ijspeert H, van Leeuwen EM, Jansen MH, Hazenberg MD, Weijer KC, van Lier RA, van der Burg M. 2011. Idiopathic CD4+ T lymphopenia without autoimmunity or granulomatous disease in the slipstream of RAG mutations. Blood 117:58925896.[CrossRef].[PubMed]
47. Ambrose M, Gatti RA. 2013. Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions. Blood 121:40364045.[CrossRef].[PubMed]
48. Felgentreff K, Perez-Becker R, Speckmann C, Schwarz K, Kalwak K, Markelj G, Avcin T, Qasim W, Davies EG, Niehues T, Ehl S. 2011. Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency. Clin Immunol 141:7382.[CrossRef].[PubMed]
49. Feske S, Gwack Y, Prakriya M, Srikanth S, Puppel SH, Tanasa B, Hogan PG, Lewis RS, Daly M, Rao A. 2006. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441:179185.[CrossRef].[PubMed]
50. Feske S, Picard C, Fischer A. 2010. Immunodeficiency due to mutations in ORAI1 and STIM1. Clin Immunol 135:169182.[CrossRef].[PubMed]
51. Tokgoz H, Caliskan U, Keles S, Reisli I, Guiu IS, Morgan NV. 2013. Variable presentation of primary immune deficiency: two cases with CD3 gamma deficiency presenting with only autoimmunity. Pediatr Allergy Immunol 24:257262.[CrossRef].[PubMed]
52. Morgan NV, Goddard S, Cardno TS, McDonald D, Rahman F, Barge D, Ciupek A, Straatman-Iwanowska A, Pasha S, Guckian M, Anderson G, Huissoon A, Cant A, Tate WP, Hambleton S, Maher ER. 2011. Mutation in the TCRα subunit constant gene (TRAC) leads to a human immunodeficiency disorder characterized by a lack of TCRαβ+ T cells. J Clin Invest 121:695702.[CrossRef].[PubMed]
53. Korthäuer U, Graf D, Mages HW, Brière F, Padayachee M, Malcolm S, Ugazio AG, Notarangelo LD, Levinsky RJ, Kroczek RA. 1993. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361:539541.[CrossRef].[PubMed]
54. Hauck F, Randriamampita C, Martin E, Gerart S, Lambert N, Lim A, Soulier J, Maciorowski Z, Touzot F, Moshous D, Quartier P, Heritier S, Blanche S, Rieux-Laucat F, Brousse N, Callebaut I, Veillette A, Hivroz C, Fischer A, Latour S, Picard C. 2012. Primary T-cell immunodeficiency with immunodysregulation caused by autosomal recessive LCK deficiency. J Allergy Clin Immunol 130:11441152.e11. doi:10.1016/j.jaci.2012.07.029.[CrossRef].[PubMed] http://dx.doi.org/doi:10.1016/j.jaci.2012.07.029
55. Kotlarz D, Ziętara N, Uzel G, Weidemann T, Braun CJ, Diestelhorst J, Krawitz PM, Robinson PN, Hecht J, Puchałka J, Gertz EM, Schäffer AA, Lawrence MG, Kardava L, Pfeifer D, Baumann U, Pfister ED, Hanson EP, Schambach A, Jacobs R, Kreipe H, Moir S, Milner JD, Schwille P, Mundlos S, Klein C. 2013. Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome. J Exp Med 210:433443.[CrossRef].[PubMed]
56. Siegel AM, Heimall J, Freeman AF, Hsu AP, Brittain E, Brenchley JM, Douek DC, Fahle GH, Cohen JI, Holland SM, Milner JD. 2011. A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. Immunity 35:806818.[CrossRef].[PubMed]
57. Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, Elias KM, Kanno Y, Spalding C, Elloumi HZ, Paulson ML, Davis J, Hsu A, Asher AI, O'Shea J, Holland SM, Paul WE, Douek DC. 2008. Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452:773776.[CrossRef].[PubMed]
58. Nadeau K, Hwa V, Rosenfeld RG. 2011. STAT5b deficiency: an unsuspected cause of growth failure, immunodeficiency, and severe pulmonary disease. J Pediatr 158:701708. (Erratum, 159:356, 2011.)[CrossRef].[PubMed]
59. Goudy K, Aydin D, Barzaghi F, Gambineri E, Vignoli M, Ciullini Mannurita S, Doglioni C, Ponzoni M, Cicalese MP, Assanelli A, Tommasini A, Brigida I, Dellepiane RM, Martino S, Olek S, Aiuti A, Ciceri F, Roncarolo MG, Bacchetta R. 2013. Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity. Clin Immunol 146:248261.[CrossRef].[PubMed]
60. Caudy AA, Reddy ST, Chatila T, Atkinson JP, Verbsky JW. 2007. CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J Allergy Clin Immunol 119:482487.[CrossRef].[PubMed]
61. Schmalstieg FC, Leonard WJ, Noguchi M, Berg M, Rudloff HE, Denney RM, Dave SK, Brooks EG, Goldman AS. 1995. Missense mutation in exon 7 of the common γ chain gene causes a moderate form of X-linked combined immunodeficiency. J Clin Invest 95:11691173.[CrossRef].[PubMed]
62. Abdollahpour H, Appaswamy G, Kotlarz D, Diestelhorst J, Beier R, Schäffer AA, Gertz EM, Schambach A, Kreipe HH, Pfeifer D, Engelhardt KR, Rezaei N, Grimbacher B, Lohrmann S, Sherkat R, Klein C. 2012. The phenotype of human STK4 deficiency. Blood 119:34503457.[CrossRef].[PubMed]
63. Mou F, Praskova M, Xia F, Van Buren D, Hock H, Avruch J, Zhou D. 2012. The Mst1 and Mst2 kinases control activation of rho family GTPases and thymic egress of mature thymocytes. J Exp Med 209:741759.[CrossRef].[PubMed]
64. Moshous D, Martin E, Carpentier W, Lim A, Callebaut I, Canioni D, Hauck F, Majewski J, Schwartzentruber J, Nitschke P, Sirvent N, Frange P, Picard C, Blanche S, Revy P, Fischer A, Latour S, Jabado N, de Villartay JP. 2013. Whole-exome sequencing identifies Coronin-1A deficiency in 3 siblings with immunodeficiency and EBV-associated B-cell lymphoproliferation. J Allergy Clin Immunol 131:15941603.[CrossRef].[PubMed]
65. Crawford G, Enders A, Gileadi U, Stankovic S, Zhang Q, Lambe T, Crockford TL, Lockstone HE, Freeman A, Arkwright PD, Smart JM, Ma CS, Tangye SG, Goodnow CC, Cerundolo V, Godfrey DI, Su HC, Randall KL, Cornall RJ. 2013. DOCK8 is critical for the survival and function of NKT cells. Blood 122:20522061.[CrossRef].[PubMed]
66. Stepensky P, Keller B, Buchta M, Kienzler AK, Elpeleg O, Somech R, Cohen S, Shachar I, Miosge LA, Schlesier M, Fuchs I, Enders A, Eibel H, Grimbacher B, Warnatz K. 2013. Deficiency of caspase recruitment domain family, member 11 (CARD11), causes profound combined immunodeficiency in human subjects. J Allergy Clin Immunol 131:477485.e1. doi:10.1016/j.jaci.2012.11.050.[CrossRef].[PubMed] http://dx.doi.org/doi:10.1016/j.jaci.2012.11.050
67. Greil J, Rausch T, Giese T, Bandapalli OR, Daniel V, Bekeredjian-Ding I, Stütz AM, Drees C, Roth S, Ruland J, Korbel JO, Kulozik AE. 2013. Whole-exome sequencing links caspase recruitment domain 11 (CARD11) inactivation to severe combined immunodeficiency. J Allergy Clin Immunol 131:13761383.e3. doi:10.1016/j.jaci.2013.02.012.[CrossRef].[PubMed] http://dx.doi.org/doi:10.1016/j.jaci.2013.02.012
68. Chun HJ, Zheng L, Ahmad M, Wang J, Speirs CK, Siegel RM, Dale JK, Puck J, Davis J, Hall CG, Skoda-Smith S, Atkinson TP, Straus SE, Lenardo MJ. 2002. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 419:395399.[CrossRef].[PubMed]
69. Lenardo MJ, Oliveira JB, Zheng L, Rao VK. 2010. ALPS—ten lessons from an international workshop on a genetic disease of apoptosis. Immunity 32:291295.[CrossRef].[PubMed]
70. Puel A, Picard C, Ku CL, Smahi A, Casanova JL. 2004. Inherited disorders of NF-κB-mediated immunity in man. Curr Opin Immunol 16:3441.[PubMed].[CrossRef]
71. Uzel G. 2005. The range of defects associated with nuclear factor κB essential modulator. Curr Opin Allergy Clin Immunol 5:513518.[PubMed].[CrossRef]
72. Lee YN, Frugoni F, Dobbs K, Walter JE, Giliani S, Gennery AR, Al-Herz W, Haddad E, LeDeist F, Bleesing JH, Henderson LA, Pai SY, Nelson RP, El-Ghoneimy DH, El-Feky RA, Reda SM, Hossny E, Soler-Palacin P, Fuleihan RL, Patel NC, Massaad MJ, Geha RS, Puck JM, Palma P, Cancrini C, Chen K, Vihinen M, Alt FW, Notarangelo LD. 2014. A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency. J Allergy Clin Immunol 133:10991108.[CrossRef].[PubMed]
73. Massaad MJ, Ramesh N, Geha RS. 2013. Wiskott-Aldrich syndrome: a comprehensive review. Ann N Y Acad Sci 1285:2643.[CrossRef].[PubMed]
74. Lanzi G, Moratto D, Vairo D, Masneri S, Delmonte O, Paganini T, Parolini S, Tabellini G, Mazza C, Savoldi G, Montin D, Martino S, Tovo P, Pessach IM, Massaad MJ, Ramesh N, Porta F, Plebani A, Notarangelo LD, Geha RS, Giliani S. 2012. A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP. J Exp Med 209:2934.[CrossRef].[PubMed]
75. Gulino AV, Moratto D, Sozzani S, Cavadini P, Otero K, Tassone L, Imberti L, Pirovano S, Notarangelo LD, Soresina R, Mazzolari E, Nelson DL, Notarangelo LD, Badolato R. 2004. Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome. Blood 104:444452.[CrossRef].[PubMed]
76. Crequer A, Troeger A, Patin E, Ma CS, Picard C, Pedergnana V, Fieschi C, Lim A, Abhyankar A, Gineau L, Mueller-Fleckenstein I, Schmidt M, Taieb A, Krueger J, Abel L, Tangye SG, Orth G, Williams DA, Casanova JL, Jouanguy E. 2012. Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections. J Clin Invest 122:32393247.[CrossRef].[PubMed]
77. Li FY, Chaigne-Delalande B, Kanellopoulou C, Davis JC, Matthews HF, Douek DC, Cohen JI, Uzel G, Su HC, Lenardo MJ. 2011. Second messenger role for Mg2+ revealed by human T-cell immunodeficiency. Nature 475:471476.[CrossRef].[PubMed]
78. Li FY, Chaigne-Delalande B, Su H, Uzel G, Matthews H, Lenardo MJ. 2014. XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus. Blood 123:21482152.[CrossRef].[PubMed]
79. van Montfrans JM, Hoepelman AI, Otto S, van Gijn M, van de Corput L, de Weger RA, Monaco-Shawver L, Banerjee PP, Sanders EA, Jol-van der Zijde CM, Betts MR, Orange JS, Bloem AC, Tesselaar K. 2012. CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia. J Allergy Clin Immunol 129:787793.e6. doi:10.1016/j.jaci.2011.11.013.[CrossRef].[PubMed] http://dx.doi.org/doi:10.1016/j.jaci.2011.11.013
80. Salzer E, Daschkey S, Choo S, Gombert M, Santos-Valente E, Ginzel S, Schwendinger M, Haas OA, Fritsch G, Pickl WF, Förster-Waldl E, Borkhardt A, Boztug K, Bienemann K, Seidel MG. 2013. Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27. Haematologica 98:473478.[CrossRef].[PubMed]
81. Geier CB, Piller A, Linder A, Sauerwein KM, Eibl MM, Wolf HM. 2015. Leaky RAG deficiency in adult patients with impaired antibody production against bacterial polysaccharide antigens. PLoS One 10:e0133220. doi:10.1371/journal.pone.0133220.[CrossRef].[PubMed] http://dx.doi.org/doi:10.1371/journal.pone.0133220
82. Mallott J, Kwan A, Church J, Gonzalez-Espinosa D, Lorey F, Tang LF, Sunderam U, Rana S, Srinivasan R, Brenner SE, Puck J. 2013. Newborn screening for SCID identifies patients with ataxia telangiectasia. J Clin Immunol 33:540549.[CrossRef].[PubMed]
83. Borte S, Fasth A, von Döbeln U, Winiarski J, Hammarström L. 2014. Newborn screening for severe T and B cell lymphopenia identifies a fraction of patients with Wiskott-Aldrich syndrome. Clin Immunol 155:7478.[CrossRef].[PubMed]
84. Shearer WT, Rosenblatt HM, Gelman RS, Oyomopito R, Plaeger S, Stiehm ER, Wara DW, Douglas SD, Luzuriaga K, McFarland EJ, Yogev R, Rathore MH, Levy W, Graham BL, Spector SA Pediatric AIDS Clinical Trials Group. 2003. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol 112:973980.[CrossRef].[PubMed]

Tables

Generic image for table
TABLE 1

CIDs, their immunophenotypes, and useful diagnostic tests

Citation: Seroogy C, Elder M. 2016. Combined Immunodeficiencies, p 721-736. In Detrick B, Schmitz J, Hamilton R (ed), Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818722.ch75

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error